Survey Reveals AI Adoption is Accelerating in Healthcare, But Readiness is Not
[Sponsored] The 2026 Healthcare AI Readiness Index, a new report by Cotiviti and MedCity News,…
Survey Reveals AI Adoption is Accelerating in Healthcare, But Readiness is Not
[Sponsored] The 2026 Healthcare AI Readiness Index, a new report by Cotiviti and MedCity News, is based on a survey of 70 healthcare leaders over the summer and shares candid views of how they balance harnessing AI with operational, regulatory and security challenges it creates. Download the report today! The post Survey Reveals AI Adoption…
The Market Forces Quietly Adding Thousands to Patient Bills
After a failed round of in vitro fertilization this year, Anne Hug’s fertility doctor said she had a single polyp in her uterus that should be removed to improve the chance of pregnancy. Hug, a professor of radiology, learned that the American College of Obstetricians and Gynecologists says the procedure can be done in a…
‘It’s Triage’: California’s Next Governor Will Face Destabilizing Surge in Uninsured
By the time Democrat Xavier Becerra left Washington, D.C., more Americans than ever had health insurance, owing partly to his work over the years to pass, defend, and expand the Affordable Care Act. It’s an achievement the former congressman and former U.S. secretary of Health and Human Services often touts as he campaigns for California…
AI’s Role in Health Care: What Keeps You Up at Night?
At the close of every episode, Chip asks his guests the same question: ‘What keeps you up at night?’ In this highlights episode, we share intriguing responses on AI’s role in health care. From deepfakes and misinformation to bias and the risk of losing the human connection at the heart of care, these highlights capture…
US Representative Scrutinizes Practices of IDR Entities
Rep. Frank Pallone, Jr., is seeking information from six IDR entities amid concerns about No Surprises Act arbitration practices and rising healthcare costs. The post US Representative Scrutinizes Practices of IDR Entities appeared first on MedCity News.
Advancing Women’s Heart Health Through Prevention and Rapid Diagnosis
Early intervention based on accurate diagnosis of both metabolic risk factors and acute cardiac events could help make the difference between life and death for women. The post Advancing Women’s Heart Health Through Prevention and Rapid Diagnosis appeared first on MedCity News.
GSK Pays $110M for Phase 1-Ready Hutchmed Asset in a New Class of Cancer Drugs
GSK gained rights to a Hutchmed antibody-targeted therapy conjugate, or ATTC. This new type of targeted therapy blocks two cancer-driving proteins and will initially be developed for lung, colorectal, and pancreatic cancers. The post GSK Pays $110M for Phase 1-Ready Hutchmed Asset in a New Class of Cancer Drugs appeared first on MedCity News.
When “Paying Correctly” Means Paying Nothing: How to Make Medicare Advantage Accountable
By FRANK LEAHY This is the second of two pieces. The first told the story of “Rick,” a 77-year-old Humana Medicare Advantage member who nearly lost his sight in a months-long runaround over a retinal detachment. This one asks what his case reveals, and what would help fix it. The runaround was exhausting – the…
Oracle Health Execs Subpoenaed After VA Contract Costs Nearly Triple
The House VA Committee voted 19-0 to subpoena Oracle Health executives Larry Ellison and Mike Sicilia after learning the VA’s EHR contract ballooned from $10 billion to $27 billion — despite Oracle’s promise to Congress that it would absorb any costs beyond the original cap. The post Oracle Health Execs Subpoenaed After VA Contract Costs…
FDA Approves Ionis Pharma Drug, the First for Ultra-Rare Alexander Disease
Ionis Pharmaceuticals’ zilganersen, brand name Zanvastro, is the first disease-modifying therapy approved for the neurological disorder Alexander disease. While Ionis has experience developing medicines for rare neuroscience indications, Zanvastro will be the first neurology product the company brings to the market without a commercialization partner. The post FDA Approves Ionis Pharma Drug, the First for…
